1,251 results on '"Sakai, Toshiyuki"'
Search Results
2. Reproductive Responses to Increased Shoot Density and Global Change Drivers in a Widespread Clonal Wetland Species, Schoenoplectus americanus
3. Development of the Split-Bolus Pulmonary Arteriovenous Separating Computed Tomography Angiography Protocol Based on Time Enhancement Curve for Lung Cancer Surgery
4. Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancer
5. Identification of c-Met as a novel target of γ-glutamylcyclotransferase
6. Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer
7. AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells
8. Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells
9. Correlation analysis of heart rate variations and glucose fluctuations during sleep
10. The NRC0 gene cluster of sensor and helper NLR immune receptors is functionally conserved across asterid plants
11. Stabilization of CDK6 by ribosomal protein uS7, a target protein of the natural product fucoxanthinol
12. HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features
13. Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells.
14. γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysis
15. The N-terminal domains of NLR immune receptors exhibit structural and functional similarities across divergent plant lineages
16. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial
17. Assessment of Platelet Thrombus Formation under Flow Conditions in Patients with Acute Kawasaki Disease
18. Figure S7 from Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells
19. Data from Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells
20. Supplementary Table2 from Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells
21. ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome
22. Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells
23. Correlation analysis of heart rate variations and glucose fluctuations during sleep
24. MO38-3 EGFR activation elicited adaptive resistance to lorlatinib in ALK-rearranged non-small cell lung cancer cells
25. MO68-4 A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS5
26. TheNRC0gene cluster of sensor and helper NLR immune receptors is functionally conserved across asterid plants
27. Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation
28. Reproductive Responses to Increased Shoot Density and Global Change Drivers in a Widespread Clonal Wetland Species, Schoenoplectus americanus
29. Tunicamycin
30. Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors
31. Jurassic NLR: conserved and dynamic evolutionary features of the atypically ancient immune receptor ZAR1
32. Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates
33. Adrenaline rush in athletes: Visualizing glucose fluctuations during high-intensity races
34. Reproductive responses to increased density and global change drivers in a widespread clonal wetland species, Schoenoplectus americanus
35. Whole-genome analysis of recombinant inbred rice lines reveals a quantitative trait locus on chromosome 3 with genotype-by-environment interaction effects
36. Data from Efficacy of Low-Dose Aspirin in Colorectal Cancer Risk Prevention is Dependent on ADH1B and ALDH2 Genotype in Japanese Familial Adenomatous Polyposis Patients
37. Supplementary Data from Efficacy of Low-Dose Aspirin in Colorectal Cancer Risk Prevention is Dependent on ADH1B and ALDH2 Genotype in Japanese Familial Adenomatous Polyposis Patients
38. Data from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
39. Supplementary Figure 4. from The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA
40. Supplementary Figure 3. from The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA
41. Supplementary Figure S4: The combination induces apoptosis in a TRAIL-independent manner in UM-UC-11 cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
42. Supplementary Figure S2: Expressions of DR5 mRNA and cell-surface DR5 are different between two bladder cancer cell lines. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
43. Supplementary Figure 2 from Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules
44. Supplementary Figure S1: Combined treatment with OBP-801 and celecoxib reduces FLIP and survivin expression at mRNA level. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
45. Supplementary Figure 1. from The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA
46. Supplementary Figure 2. from The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA
47. Suuplementary Figure S3: Combined treatment with OBP-801 and celecoxib induces binding of caspase-8 to DR5, and Bim expression in bladder cancer cells. from A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells
48. Supplementary Figure 1 from Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules
49. Supplementary table from The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA
50. Supplementary Data from Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.